Drug Repurposing Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Disease Indication (Oncology, CNS Diseases, Neurodegenerative diseases, Others); End User (Hospitals, Ambulatory Surgical Centers, Others), and Geography

Report Code: TIPRE00016853 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Drug repurposing is also known as drug repositioning. It is a process of identifying new therapeutic use(s) for old/existing/available drugs. It is an effective strategy in developing or discovering drug molecules with new therapeutic indications. In recent years, many pharmaceutical companies are developing new drugs with the discovery of novel biological targets by applying the drug repositioning strategy in drug discovery and development programs. This strategy is highly efficient, low-cost, time-saving, and minimum risk of failure. It increases the therapeutic value of a drug and consequently maximizes the success rate. Drug repositioning is thus an important alternative method to the conventional process of drug development.

MARKET DYNAMICS

Factors driving the growth of the drug repurposing market are the growing need for the low investment in terms of time and money is boosting demand for the drug repurposing which is leading to an increase in the number of pipeline products is propelling the growth of the drug repurposing market. Additionally, some of the other factors propelling the growth of the global drug repurposing market are low research cost and easy bioavailability is fueling the market growth. However, lack of funding and limited information is expected to hamper the growth of the market.

MARKET SCOPE

The "Drug Repurposing Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of drug repurposing market with detailed market segmentation by disease indication and end user. The drug repurposing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in drug repurposing market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The drug repurposing market is segmented on the basis of disease indication and end user. Based on disease indication, the market is segmented as oncology, CNS diseases, neurodegenerative diseases, and others. On the basis of end user, the market is categorized as hospitals, ambulatory surgical centers, and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the drug repurposing market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The drug repurposing market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting drug repurposing market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the drug repurposing market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the drug repurposing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from drug repurposing market are anticipated to have lucrative growth opportunities in the future with the rising demand for drug repurposing in the global market. Below mentioned is the list of few companies engaged in the drug repurposing market.

The report also includes the profiles of key players in drug repurposing market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Astellas Pharma Inc.
  •  Biovista
  •  Novartis AG
  •  AbbVie Inc.
  •  Pfizer Inc.
  •  Allergan Plc.
  •  NuMedii
  •  Abbott Healthcare
  •  Hoffmann-La Roche
  •  Johnson & Johnson.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Drug Repurposing Market - By Disease Indication
1.3.2 Drug Repurposing Market - By End User
1.3.3 Drug Repurposing Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. DRUG REPURPOSING MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. DRUG REPURPOSING MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. DRUG REPURPOSING MARKET - GLOBAL MARKET ANALYSIS
6.1. DRUG REPURPOSING - GLOBAL MARKET OVERVIEW
6.2. DRUG REPURPOSING - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. DRUG REPURPOSING MARKET - REVENUE AND FORECASTS TO 2028 - DISEASE INDICATION
7.1. OVERVIEW
7.2. DISEASE INDICATION MARKET FORECASTS AND ANALYSIS
7.3. ONCOLOGY
7.3.1. Overview
7.3.2. Oncology Market Forecast and Analysis
7.4. CNS DISEASES
7.4.1. Overview
7.4.2. CNS Diseases Market Forecast and Analysis
7.5. NEURODEGENERATIVE DISEASES
7.5.1. Overview
7.5.2. Neurodegenerative diseases Market Forecast and Analysis
7.6. OTHERS
7.6.1. Overview
7.6.2. Others Market Forecast and Analysis
8. DRUG REPURPOSING MARKET - REVENUE AND FORECASTS TO 2028 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. AMBULATORY SURGICAL CENTERS
8.4.1. Overview
8.4.2. Ambulatory Surgical Centers Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. DRUG REPURPOSING MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Drug Repurposing Market Overview
9.1.2 North America Drug Repurposing Market Forecasts and Analysis
9.1.3 North America Drug Repurposing Market Forecasts and Analysis - By Disease Indication
9.1.4 North America Drug Repurposing Market Forecasts and Analysis - By End User
9.1.5 North America Drug Repurposing Market Forecasts and Analysis - By Countries
9.1.5.1 Canada Drug Repurposing Market
9.1.5.1.1 Canada Drug Repurposing Market by Disease Indication
9.1.5.1.2 Canada Drug Repurposing Market by End User
9.1.5.2 Mexico Drug Repurposing Market
9.1.5.2.1 Mexico Drug Repurposing Market by Disease Indication
9.1.5.2.2 Mexico Drug Repurposing Market by End User
9.1.5.3 US Drug Repurposing Market
9.1.5.3.1 US Drug Repurposing Market by Disease Indication
9.1.5.3.2 US Drug Repurposing Market by End User
9.2. EUROPE
9.2.1 Europe Drug Repurposing Market Overview
9.2.2 Europe Drug Repurposing Market Forecasts and Analysis
9.2.3 Europe Drug Repurposing Market Forecasts and Analysis - By Disease Indication
9.2.4 Europe Drug Repurposing Market Forecasts and Analysis - By End User
9.2.5 Europe Drug Repurposing Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Drug Repurposing Market
9.2.5.1.1 Germany Drug Repurposing Market by Disease Indication
9.2.5.1.2 Germany Drug Repurposing Market by End User
9.2.5.2 France Drug Repurposing Market
9.2.5.2.1 France Drug Repurposing Market by Disease Indication
9.2.5.2.2 France Drug Repurposing Market by End User
9.2.5.3 Italy Drug Repurposing Market
9.2.5.3.1 Italy Drug Repurposing Market by Disease Indication
9.2.5.3.2 Italy Drug Repurposing Market by End User
9.2.5.4 Spain Drug Repurposing Market
9.2.5.4.1 Spain Drug Repurposing Market by Disease Indication
9.2.5.4.2 Spain Drug Repurposing Market by End User
9.2.5.5 United Kingdom Drug Repurposing Market
9.2.5.5.1 United Kingdom Drug Repurposing Market by Disease Indication
9.2.5.5.2 United Kingdom Drug Repurposing Market by End User
9.2.5.6 Rest of Europe Drug Repurposing Market
9.2.5.6.1 Rest of Europe Drug Repurposing Market by Disease Indication
9.2.5.6.2 Rest of Europe Drug Repurposing Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Drug Repurposing Market Overview
9.3.2 Asia-Pacific Drug Repurposing Market Forecasts and Analysis
9.3.3 Asia-Pacific Drug Repurposing Market Forecasts and Analysis - By Disease Indication
9.3.4 Asia-Pacific Drug Repurposing Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Drug Repurposing Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Drug Repurposing Market
9.3.5.1.1 Australia Drug Repurposing Market by Disease Indication
9.3.5.1.2 Australia Drug Repurposing Market by End User
9.3.5.2 China Drug Repurposing Market
9.3.5.2.1 China Drug Repurposing Market by Disease Indication
9.3.5.2.2 China Drug Repurposing Market by End User
9.3.5.3 India Drug Repurposing Market
9.3.5.3.1 India Drug Repurposing Market by Disease Indication
9.3.5.3.2 India Drug Repurposing Market by End User
9.3.5.4 Japan Drug Repurposing Market
9.3.5.4.1 Japan Drug Repurposing Market by Disease Indication
9.3.5.4.2 Japan Drug Repurposing Market by End User
9.3.5.5 South Korea Drug Repurposing Market
9.3.5.5.1 South Korea Drug Repurposing Market by Disease Indication
9.3.5.5.2 South Korea Drug Repurposing Market by End User
9.3.5.6 Rest of Asia-Pacific Drug Repurposing Market
9.3.5.6.1 Rest of Asia-Pacific Drug Repurposing Market by Disease Indication
9.3.5.6.2 Rest of Asia-Pacific Drug Repurposing Market by End User
9.4. SOUTH AND CENTRAL AMERICA
9.4.1 South and Central America Drug Repurposing Market Overview
9.4.2 South and Central America Drug Repurposing Market Forecasts and Analysis
9.4.3 South and Central America Drug Repurposing Market Forecasts and Analysis - By Disease Indication
9.4.4 South and Central America Drug Repurposing Market Forecasts and Analysis - By End User
9.4.5 South and Central America Drug Repurposing Market Forecasts and Analysis - By Countries
9.4.5.1 Brazil Drug Repurposing Market
9.4.5.1.1 Brazil Drug Repurposing Market by Disease Indication
9.4.5.1.2 Brazil Drug Repurposing Market by End User
9.4.5.2 Argentina Drug Repurposing Market
9.4.5.2.1 Argentina Drug Repurposing Market by Disease Indication
9.4.5.2.2 Argentina Drug Repurposing Market by End User
9.4.5.3 Rest of South and Central America Drug Repurposing Market
9.4.5.3.1 Rest of South and Central America Drug Repurposing Market by Disease Indication
9.4.5.3.2 Rest of South and Central America Drug Repurposing Market by End User
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL DRUG REPURPOSING MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. DRUG REPURPOSING MARKET, KEY COMPANY PROFILES
12.1. ASTELLAS PHARMA INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BIOVISTA
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. NOVARTIS AG
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. ABBVIE INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. PFIZER INC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ALLERGAN PLC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. NUMEDII
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. ABBOTT HEALTHCARE
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. HOFFMANN-LA ROCHE
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. JOHNSON & JOHNSON
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Astellas Pharma Inc.
2. Biovista
3. Novartis AG
4. AbbVie Inc.
5. Pfizer Inc.
6. Allergan Plc.
7. NuMedii
8. Abbott Healthcare
9. Hoffmann-La Roche
10. Johnson & Johnson
TIPRE00016853
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking